Podcasts about Color Genomics

Send us a textLinda Jiang is Head of Strategy and Government Partnerships, Healthcare, at Lyft ( https://www.lyft.com/healthcare ), where she's responsible for accelerating the growth of the business, driving public sector strategy, and partnering with policymakers and regulators to bring access to the rideshare service to millions of people who need it for healthcare access.Previously, Linda was an early growth operator at healthcare startups, leading strategy for Modern Fertility and consumer marketing for Color Genomics. Linda began her career as a management consultant at PwC, with clients including academic medical centers, top integrated healthcare systems, medical device companies, and big box retailers, and also had a role in corporate strategy at Twitter. She holds a Master of Public Health (MPH) and a Bachelor of Science, Neuroscience and Behavioral Biology from Emory University.#Lyft #RideShare #NonEmergencyMedicalTransportation #SocialDeterminantsOfHealth #Health #Wellbeing #MedicareAdvantage #Medicaid #MaternalHealth #AgingInPlace #Loneliness #Isolation #SocialConnection #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

Elad Gil is a serial entrepreneur, executive, and one of the greatest tech investors of all time, with early stakes in something like 40 billion-plus dollar companies: AirBnB, Anduril, Coinbase, Figma, Flexport, Instacart, Notion, OpenDoor, Pinterest, Square, Stripe… I could really go on. He's now managing a new billion dollar venture fund, for which he's the sole investor. Elad is also the co-founder of 2 companies: Color Genomics, a company providing genetic testing, software and clinical services for large-scale health programs – and before that, Mixer Labs, a company building location infrastructure for mobile devices that was acquired by Twitter. He worked as a VP at Twitter and also started the mobile team at Google. 0:00 - Intro 6:11 - Blank Slates and Decaying Institutions 8:16 - Western Pessimism and Agendas of Abundance vs Scarcity 12:30 - The Long Boom: Is Innovation Speeding Up? 16:26 - Are Startups Founder Limited or Market Limited? 19:26 - EIR Syndrome and Choosing the Right Market 21:41 - What Makes for a Good Investor, Operator and Entrepreneur? 24:05 - Positives and Negatives of Investing and Operating 26:17 - The Brand Value of Individuals vs Institutions 28:05 - Competing with Massive Firms 30:33 - Market-Driven Investing 33:23 - Starting Companies as Surfing Waves 36:09 - Age of Accomplishment and The Deferral of Adulthood 42:15 - What to Say Yes To 44:21 - Defense Tech and Complacency 49:25 - Private Markets and The Future of Venture 52:11 - Discontinuities in AI 53:49 - On Google 55:16 - LLM Oligopoly and Long-Term Scenarios for AI 1:00:41 - AGI and Sleeping 3 Hours a Night 1:03:19 - AI Doomerism 1:06:05 - The Deterioration of Speed 1:09:27 - Bureaucracy and the State of Nuclear 1:12:52 - Generosity and the Culture of Silicon Valley 1:15:19 - What Should More People Be Thinking About?

Warp: Don't let payroll and compliance hold your startup back: visit https://joinwarp.com/peel to get started and receive a $1,000 gift card when you first run payroll. Get Attio, the next generation of CRM: https://bit.ly/AttioThePeel Elad Gil is the founder of Color Genomics and Mixer Labs, which he sold to Twitter, and an early investor in iconic companies like Airbnb and Stripe, plus upstarts like Perplexity and Anduril. This is a wide ranging conversation that covers education, AI, and advice for building a startup. Timestamps (00:00) Intro (03:46) Building cool monuments (09:12) Fixing education (16:38) Why AI is underhyped (19:02) Four trends to watch in AI (19:55) Why there aren't large biotech companies (23:21) The current state of Elad Gill (24:32) How he incubates companies (26:32) Contemplating AI-driven buyouts (27:29) His investing strategy, from early to late stage (36:57) Why he remained solo for so long (40:19) How to get conviction in unpopular investments (42:53) What made Steve Jobs a good communicator (44:00) The importance of ambition and leadership (46:28) Why Elad puts so much weight in the market (47:45) The evolution of Google's business model (49:17) How to monetize consumer products (50:06) Analyzing a potential startup market (51:23) How successful products eventually become distribution companies (56:30) Non-obvious startup advice (59:54) When its OK to give up (01:02:20) Advice on raising your first round (01:03:21) Picking board members (01:04:45) How to hire your first three employees (01:06:48) Avoiding bad hires (01:08:39) The importance of speed of execution (01:12:36) Why he's adding to his team (01:14:31) Gardening Referenced: Elad's Blog: https://blog.eladgil.com/ Elad's Podcast: https://www.youtube.com/@NoPriorsPodcast/ Elad's Book: https://growth.eladgil.com/ Where to find Elad: Twitter: https://twitter.com/eladgil LinkedIn: https://www.linkedin.com/in/eladgil Celine's Website: https://eladgil.com/ Where to find Turner: Twitter: https://twitter.com/TurnerNovak LinkedIn: https://www.linkedin.com/in/turnernovak/ Newsletter: https://www.thespl.it/

Elad Gil has now launched two startups of his own. He sold one to Twitter, and has raised almost half a billion dollars for a second. That's along with investing in some of today's most successful companies, like Stripe, Airbnb, and Coinbase. His latest startup, Color Genomics, has attracted funding from top-tier investors like T. Rowe Price, Kindred Ventures, Pegasus Tech Ventures, and General Catalyst.

Elad Gil is an entrepreneur, operator, and and investor. He has invested in and advised companies such as AirBnB, Stripe, Figma, Airtable, Samsara, Coinbase, Flexport, Gitlab, Gusto, Instacart, Notion, Pinterest, Rippling, and many more. He was the cofounder and Chairman at Color Genomics. Prior to that, was the VP of Corporate Strategy at Twitter. He was the cofouder and CEO MixerLabs, which got acquired by Twitter. He has held roles at Google and McKinsey. He has a PhD from MIT. In this episode, we cover a range of topics including:  - How will the AI market structure evolve? - What products can startups build to make LLMs faster/better/cheaper? - How is Generative AI being used in the enterprise today? - How are customers spending money for AI-related work? - What is AutoGPT and how can businesses use it? - What AI copilot products can be built? - How are LLMs being used for software development? - How will the AI infrastructure market shape up? - Building a moat for AI-infused businesses - Open source opportunities in AI - What's the state of play in the AI application market? -------- Where to find Prateek Joshi: Newsletter: https://prateekjoshi.substack.com Website: https://prateekj.com LinkedIn: https://www.linkedin.com/in/prateek-joshi-91047b19 Twitter: https://twitter.com/prateekvjoshi 

What does the future hold for shielded transactions? How can #shieldedtransactions/#privacy-protecting initiatives change the way we interact in society? What can we do to safeguard our identities in the future of this #crypto economy? Are there certain utopias and dystopias to embrace or to avoid?*Avichal Garg, Electric Capital | Shielded Transaction Special | Trailer*Avichal Garg is a co-founder and partner on the investment team at Electric Capital. He is a successful serial entrepreneur with executive experience at Google and Facebook, which acquired his previous company in 2012. At Facebook he was Director of Product Management for the Local product group, a team of 400 engineers responsible for billions in revenue.Prior to Electric, Avichal was an investor in crypto projects such as Anchorage, Bitwise, Celo, dYdX, Lightning Labs, and OpenSea and unicorns such as Airtable, Boom Supersonic, Color Genomics, Cruise, Deel, Figma, Material Secutiy, Newfront Insurance, Notion, Nova Credit, and Pulley.https://avichal.com/The Foresight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.Allison Duettmann is the president and CEO of Foresight Institute. She directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, Fellowships, Prizes, and Tech Trees, and shares this work with the public. She founded Existentialhope.com, co-edited Superintelligence: Coordination & Strategy, co-authored Gaming the Future, and co-initiated The Longevity Prize. Apply to Foresight's virtual salons and in person workshops here!We are entirely funded by your donations. If you enjoy what we do please consider donating through our donation page.Visit our website for more content, or join us here:TwitterFacebookLinkedInEvery word ever spoken on this podcast is now AI-searchable using Fathom.fm, a search engine for podcasts.  Hosted on Acast. See acast.com/privacy for more information.

In the world of startups, Elad Gil has done it all. He's been an executive, entrepreneur, investor, or advisor for so many successful companies: Airbnb, Gusto, Stripe, Square, Google and Twitter, to name a few.  Today he is the co-founder of Color Genomics and describes himself as A Startup Helper. We couldn't agree more.In a conversation with the entire Latitud Team, Elad talked about:the current state of startupsheadcount and budget adjustmentsaccess to investmentand how he chooses where to focus his time and energy.Hey, apply to be a fellow, open your startup or sign up for our newsletter.Follow us on Linkedin / Twitter / Instagram / Podcast.

It is not a stretch to call Elad Gil one of Silicon Valley's best investors.  In a world where one big hit can make a venture capitalists' career, Elad has invested in…Well, here's a partial list Airbnb, Airtable, Anduril, Brex, Checkr, Coinbase, Deel, Figma, Flexport, Gitlab, Gusto, Instacart, Notion, Opendoor, PagerDuty, Pinterest, Retool, Rippling, Samsara, Square, Stripe, TripActions, Wish. It seems almost impossible.  But there it is.  Elad's career includes working at Google, founding a company acquired by Twitter, and founding Color Genomics (you probably heard about them during the COVID response). He is also author of the book High Growth Handbook: Scaling Startups from 10 to 10,000 People. In this wide-ranging discussion, Elad shares his thoughts on everything from building companies to crypto, AI, and more.   Elad's home page:      https://eladgil.com/ Elad on Twitter:          https://twitter.com/eladgil Something Ventured: https://somethingventured.us/   

Katie Stanton is founder and general partner of Moxxie Ventures after an illustrious career ranging from politics to genetics. She has held leading operating roles as a VP at Twitter, Chief Marketing Officer at Color Genomics, and Principal at Google. She has also held positions at the Obama White House and Clinton State Department.In this episode, Katie shares playbooks for understanding market development, creating content flywheels, and how to think about career choices. Katie was a 10/10 guest and we hope to have her back soon.--- Execs is a show for founders, operators, and pioneers who want to understand the playbooks, frameworks, and tactics that leading tech companies today have used to scale.  To engage further:  Check out the On Deck job board Share your thoughts with us on Twitter:  Hosted by: @eriktorenberg Featuring guest: @morganbProduced by: @jacksonsteger Brought to you by: @beondeck 

In this episode, we have Nishant Bhat, serial entrepreneur who co-founded Color Genomics, which is valued at over $4.6 billion, and BioTech investor, having launched the https://scifounders.com/ (SciFounder Fellowship) to invest in budding BioTech companies. We talk about Nish's journey, from having grown up with East Asian and Indian culture, to his career successes, to his transition to providing opportunities and guidance to budding scientist-entrepreneurs. This is all the while maintaining humility and appreciation for the people and environment that made him the way his is, without yielding it to it by losing drive. Beyond that, Nish is also a passionate diver, foodie, and chef. You can reach out to Nish on https://www.linkedin.com/in/nmbhat/ (LinkedIn). --------------------------------------- 9 Ways To Become A Fulfilled, Badass Asian DudeDownload the collection of wisdom from our podcast guests on how to become a Badass Asian Dude: http://badassasiandudes.com/subscribe (http://badassasiandudes.com/subscribe). Support this show and the movement:Cop yourself some merch at http://badassasiandudes.com/ (http://badassasiandudes.com). Share this episode with one of your brothers! Connect with us:Follow the Instagram at http://instagram.com/badassasiandudesofficial (http://instagram.com/badassasiandudesofficial) Join the other 1200+ Badass Asian Dudes on Facebook: http://facebook.com/groups/badassasiandudes (http://facebook.com/groups/badassasiandudes) Subscribe to our newsletter for actionable advice and wisdom, as well as discounts and meetups at http://badassasiandudes.com/subscribe (http://badassasiandudes.com/subscribe)

Nat Turner is currently CEO of Collectors Holdings after taking CLCT private from the Nasdaq for nearly $1 Billion. The holding company is focused on the collectibles industry - including PSA (trading card grading), PCGS (coin grading), Wata Games (video game grading), and Goldin Auctions. Before Collectors Holdings, Nat built and exited two companies - Flatiron Health, a technology company focused on the oncology industry, was acquired by Roche for $1.9 Billion in 2018. Invite Media, an advertising technology company based in NYC, was acquired by Google in 2010. An active angel investor since 2010, Nat has invested in over 250 startups, including BarkBox, Cedar, Clover Health, Color Genomics, Oscar, and Plaid.

Elad Gil — most recently co-founder of Color Genomics, previously co-founder and CEO of Mixer Labs, which was acquired by Twitter. He was a  VP at Twitter focusing on scaling the company from 90 to 1500 people. Previously at Google he started their mobile team, and worked on AdSense. He is also flat out one of the best angel investors/advisors in the startup community. His portfolio includes Airbnb, Airtable, Anduril, Brex, Checkr, Coinbase, Flexport, Gitlab, Gusto, Instacart, Opendoor, PagerDuty, Pinterest, Samsara, Square, Stripe, and Wish.He has a kind of sight that makes the nonobvious appear obvious. (Interviewed by StartupGrind's Chris Joannou). 

The High Growth Handbook Global technology executive, serial entrepreneur, and angel investor Elad Gil has worked with high-growth, tech companies like Airbnb, Twitter, Google, Stripe, and Square as they've grown from small companies to global enterprises. Across all of these breakout companies, a set of common patterns has evolved into a repeatable playbook that Gil has now codified in High Growth Handbook. In this definitive guide, Gil covers key topics, including: * the role of the CEO * managing a board * recruiting and managing an executive team * mergers and acquisitions * initial public offerings * late-stage funding Interspersed with and informed by interviews with some of the biggest names in Silicon Valley including Reid Hoffman (LinkedIn), Marc Andreessen (Andreessen Horowitz), and Aaron Levie (Box), High Growth Handbook presents crystal-clear guidance for navigating the most complex challenges that confront leaders and operators in high-growth startups. Takeaways Avoid the three things that kill early-stage companies Failing to find Product/Market Fit. PMF is much rarer than most people imagine. The best signal is the ability to raise prices repeatedly without losing customers. Co-founder conflicts. Problems arise when there is a lack of clarity on decision making, product vision, and overlapping founder roles. A startup's main advantage is speed: conflict eliminates the advantage. If you can't work together, one of you should leave. Running out of cash. Every business will make errors as it develops; cash on hand provides a margin of safety. Shift from product focus to distribution focus As companies grow, individual products become less important, and focus has to shift towards the distribution of multiple products. The most successful companies have powerful distribution engines. About the author Elad Gil, an entrepreneur, operating executive, and investor or advisor to private companies such as Airbnb, Coinbase, Checkr, Gusto, Instacart, OpenDoor, Pinterest, Square, Stripe, Wish. He is cofounder and chairman at Color Genomics. Elad was the VP of Corporate Strategy at Twitter, where he also ran product (Geo, Search) and operational teams (M&A and Corporate Development). Elad joined Twitter via the acquisition of MixerLabs, where he was co-founder and CEO. Elad spent many years at Google, where he started the mobile team-involved in all aspects of getting it up and running. He was involved with three acquisitions (including the Android team) and was the original product manager for Google Mobile Maps. Prior to Google, Elad had product management and market-seeding roles at a number of Silicon Valley companies. Host rating for 'The High Growth Handbook' Nico Rating: 4/10 Sam Rating: 7/10 Subscribe! If you enjoyed the podcast please subscribe and rate it. And of course, share with your friends!

Elad Gil is an entrepreneur, operating executive, and investor or advisor to private companies such as Airbnb, Coinbase, Checkr, Gusto, Instacart, OpenDoor, Pinterest, Square, Stripe, Wish. He is cofounder and chairman at Color Genomics. He was the VP of Corporate Strategy at Twitter, where he also ran product (Geo, Search) and operational teams (M&A and Corporate Development). Elad joined Twitter via the acquisition of MixerLabs, where he was co-founder and CEO. Elad spent many years at Google, where he started the mobile team-involved in all aspects of getting it up and running. He was involved with three acquisitions (including the Android team) and was the original product manager for Google Mobile Maps. Elad received his Ph.D. from the Massachusetts Institute of Technology and has degrees in Mathematics and Biology from the University of California, San Diego. In conversation with Matt Harrigan, CEO & Managing Partner @ Company Ventures.

Researchers have tracked the evolution of genetic germline testing in women with breast or ovarian cancer in recent years and reported the results in the Journal of Clinical Oncology. Study author Allison W. Kurian, MD, of Stanford (Calif.) University, describes the group’s findings (https://bit.ly/31RaSGR) to guest host Alan Lyss, MD, subprincipal investigator emeritus for Heartland Cancer Research NCORP, in this episode. Study rationale and methods Dr. Kurian said that an inflection point for breast cancer genetics was in 2013 when the U.S. Supreme Court ruled that gene patenting was not allowed for the purposes of genetic testing. As a result, the cost of testing BRCA1/2 genes fell, and testing became much more accessible. With their study, Dr. Kurian and colleagues aimed to look at trends following the increase in accessibility. The researchers used Surveillance, Epidemiology, and End Results Program (SEER) records of women aged 20 years and older who were diagnosed with breast or ovarian cancer from 2013 to 2017 in California or Georgia. The team linked these data to results of clinical germline testing through 2019. Dr. Kurian explained that the SEER data are comprehensive enough that all cancer cases in California and Georgia were likely included, the states provide a large catchment area of about 50 million people, and the states have different kinds of racial/ethnic diversity and urban/rural distribution. The researchers used the data to assess testing trends as well as rates of variants of uncertain significance (VUS) and pathogenic variants (PVs). Results by hypothesis Hypothesis 1: Multigene panels will entirely replace testing for BRCA1/2 only. This hypothesis was essentially correct. Testing of only two genes was almost totally replaced by testing many more genes. The number of genes tested for breast cancer increased annually by 28% over the study period. Hypothesis 2: Underutilization of testing patients with ovarian cancer will improve over time. It is standard of care to recommend genetic testing for all ovarian cancer patients. Based on 2013-2014 data, only one-third of women were tested. As tests became more accessible in subsequent years, the hope was that more women would be tested. Unfortunately, there was very little improvement in testing rates over the study period. Hypothesis 3: More patients will be tested at lower levels of pretest risk for PVs. In patients aged older than 60 years, testing rates increased for breast cancer (from 11% to 15%) and ovarian cancer (from 25% to 31%). Patients aged younger than 45 years had lower testing rates over time, however. Dr. Kurian noted that about 33% of ovarian cancer patients undergo genetic testing, but the goal is 100%. It is unclear if the goal should be 100% for breast cancer, Dr. Kurian said. Hypothesis 4: Sociodemographic difference in testing trends would not be seen. There was not much of a gap observed with breast cancer patients. For example, among patients with breast cancer, approximately 31% of those who had genetic testing were uninsured, 31% had Medicaid, and 26% had private insurance or Medicare. There is more of an equity issue with ovarian cancer. About 28% of those who had genetic testing were uninsured, 27% had Medicaid, and 39% had private insurance or Medicare. Dr. Kurian said disparities in ovarian cancer persist in patients who are uninsured and those in certain racial/ethnic groups, including African Americans. These patients are less likely to get genetic testing. Hypothesis 5: Detection of PVs and VUS will increase. The detection of VUS increased at a higher rate in comparison with PVs when more genes were being tested. This is likely because of the fact that, for every PV you find, you will find many more VUS, Dr. Kurian said. Hypothesis 6: Racial or ethnic disparities in rates of VUS will diminish over time. Disparities actually increased over the study period as more genes were tested. Some studies have suggested that VUS results lead to unnecessary prophylactic surgery, Dr. Kurian said. She added that the decision to undergo prophylactic surgery should not be based on a VUS because “the great majority of VUS turn out to be nothing.” Additional findings and implications for practice The study revealed that most PVs were in 20 genes associated with breast or ovarian cancer. Dr. Kurian and colleagues concluded that the way to improve testing is to focus on those 20 genes and ensure appropriate patients are being tested, rather than adding more genes to tests. Dr. Kurian said it is urgent to increase genetic testing in patients with ovarian cancer, as it is not being done at the rate it should be. Dr. Kurian also noted that one positive outcome of the COVID-19 pandemic has been an increase in telehealth visits and at-home genetic testing. Providing patients with these more convenient options could increase the use of genetic testing. Show notes written by Alesha Levenson, MD, a resident at Penn Medicine, Philadelphia. Disclosures Dr. Kurian disclosed relationships with Myriad Genetics, Ambry Genetics, Color Genomics, GeneDx/BioReference, InVitae, and Genentech. The study was supported by the National Cancer Institute, the Centers for Disease Control and Prevention, and the California Department of Public Health. Dr. Lyss writes a column for MDedge Hematology/Oncology called “Clinical Insights” (https://bit.ly/3m76xIP). He has no other conflicts of interest. *  *  * For more MDedge Podcasts, go to mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgehemonc Dr. Lyss on Twitter: @HeartlandOncDoc

We're (almost) back in session! The Entrepreneurial Thought Leaders series returns on April 14, with a brand new lineup that includes Ulu Ventures managing director Miriam Rivera; Cloudflare co-founder, president and COO Michelle Zatlyn; and the Miami Heat’s Andre Iguodala.

Listen now (35 min) | Non-traditional paths into venture have been a common theme among many emerging managers, and our guest this week, Katie Jacobs Stanton, founder of Moxxie Ventures, is no exception. Katie started her career as a Banker at JP Morgan, but subsequently worked within the Obama White house as special advisor to the office of innovation, and she had operator roles at Twitter, Google, Yahoo, and Color Genomics. She was also named by Forbes as the #56 on the most powerful women in the world. Get on the email list at ventureunlocked.substack.com

On today’s episode, we hear from Elad Gil, the co-founder of Mixer Labs and Color Genomics, investor and advisor to a multitude of companies, and author of “High Growth Handbook”. Listen in to learn about Elad’s biggest takeaways from working at Google and Twitter, and his answers to some of the tougher questions around founding and investing, like what do you do when an employee isn’t scaling with a company? Or how do you diligence a company in a market so forward thinking it doesn’t exist yet?Find out more about Elad’s book here: https://growth.eladgil.com/

Elad is an entrepreneur and operating executive as well as an investor or advisor to a number of successful companies including AirBnB, Airtable, Coinbase, Flexport, Gusto, Instacart, Opendoor, Pinterest, Square, Stripe, and Wish. He previously was the co-founder and CEO Color Genomics and before that Mixer Labs which was acquired by Twitter. Elad served as the VP of Corporate Strategy at Twitter where he helped the company scale from 90 to 1,500 employees. He previously started the mobile team at Google. Elad is the author of High Growth Handbook, and writes more on his blog at blog.eladgil.com. [1:52] - Elad's value-add as a startup investor, board member, and advisor [4:27] - Why he evaluates product-market first and foremost [9:53] - The changing role of geographical location for startups [15:11] - How crypto today compares to the early years of the internet [21:25] - Creating a virtual world with pluto.video [23:23] - Maximizing the growth of early successes [26:44] - Balancing founding principles with an evolving company culture [29:34] - The growth of founders in parallel to their companies [32:01] - How advisors and board members can influence a company's success [35:26] - How to identify the best additions to an executive team [39:54] - Time management through delegation and other strategies [46:30] - Elad's interest in longevity and perspective on the field -- Thank you for listening to Pod of Jake! All shares and reviews are sincerely appreciated! LINKS: Twitter: @blogofjake Website: podofjake.com Blog: blogofjake.com Email: jake@blogofjake.com Call: superpeer.com/jake Support: patreon.com/blogofjake Bitcoin: 3ESGQxrJZmGqd2SifqCUiHPvah1uWtN1Zd Ethereum: blogofjake.eth 0xF89aCC1f8c4FeEAc372997006BfE7c0fdD99F80c Bitcoin Cash: qznma8vxf8kjn4v9phsfkhzd0559gm7yfsx0gkl4sf

Founder's FAQ: answers to all the possible questions of a founder. Hosted by Ilker Koksal. This episode's guest is Elad Gil. Elad is an entrepreneur, operating executive, and investor to companies such as Airbnb, Coinbase, Checkr, Gusto, Instacart, OpenDoor, Gitlab, Brex, Pinterest, Square, Stripe, Wish, and many more. He is co-founder at Color Genomics and its former CEO. Previously, he was VP of corporate strategy at Twitter after it acquired his firm Mixer Labs, and he was Google's original product manager for Google Mobile Maps. And lastly, he is the author of High Growth Handbook.In this episode;1-) Advice to founders in today's capital-rich environment2-) Where to start a company3-) What to look for while getting a co-founder4-) Scaling in a remote era5-) What's going to be a unicornFounder's FAQ is a book for founders and you can pre-order through the website. You can also reach us through @foundersfaq on Twitter, LinkedIn, Instagram, and YouTube.

Avichal is a successful serial entrepreneur with executive experience at Google and Facebook, which acquired his previous company. At Facebook he was Director of Product Management for the Local product group. Avichal is an investor in companies such as Airtable, Boom Supersonic, Color Genomics, Cruise, Figma, Newfront Insurance, Notion, Nova Credit, Threads, and others. Electric Capital is a venture firm that invests in cryptocurrencies, blockchain based businesses, fintech companies, and marketplaces. Electric Capital and its founders have invested in crypto companies such as Anchorage, Bitwise, Celo, Coda, Coinbase, Derivadex, Mobilecoin, Oasis, and NEAR. LinkedIn: https://www.linkedin.com/in/avichalgarg/ Twitter: https://twitter.com/avichal Website: https://avichal.com

Our latest episode is a fireside chat between Armando Mann, Chief Business Officer at Hopin, and Elad Gil,  entrepreneur, investor, and author. Elad walks us through how he sees companies coming out of the pandemic, the offensive and defensive moves a startup can take to protect themselves from uncertainties that arise during a pandemic, how companies can leverage the pandemic to recruit the best talent, explore new opportunities in mergers and acquisitions and go after enterprise clients. The future of remote work, the urgent needs, and problems startups are not addressing, what new technology Elad is most excited about, and much more.   Listen in.Get $10,000 free credits to use Freshworks products (including the brand new Freshworks CRM packed with AI-based lead scoring, phone, email, activity capture, and more) by joining the Freshworks for Startups program. Click here to check eligibility. About the GuestElad Gil is an entrepreneur, operating executive, and investor or advisor to private companies such as Airbnb, Coinbase, Checkr, Gusto, Instacart, OpenDoor, Pinterest, Square, Stripe, and Wish. He is co-founder and chairman at Color Genomics and its former CEO. Previously, Gil was VP of corporate strategy at Twitter after it acquired his firm Mixer Labs, and he was Google's original product manager for Google Mobile Maps.About the HostArmando Mann is Chief Business Officer at Hopin, the leading platform for virtual events where you can host a 50 person meetup or a 50,000 person conference. He is also a global investor in SaaS startups such as Carta, Blend, and Freshworks. Armando launched and led go to market for Dropbox for Business. Before that, he built the sales teams for various Google emerging businesses, including Google Offers and AdWords Express. Armando holds an Industrial Engineering degree from ITBA and a Master in Business Administration from the Harvard Business School, where he graduated as a Baker Scholar.Sign up for regular updates from The Orbit Shift Podcast.The Orbit Shift Podcast is Powered by Freshworks Inc. a global SaaS company headquartered in San Mateo, California. If you enjoyed listening to this podcast, consider giving us a five-star rating on Apple Podcasts. Host and Producer - Jayadevan PKAssistant Producer - Shashwath JAudio Engineer - Rajesh Subramanian 

Nikhil is a venture capitalist who spent several years at Shasta Ventures after beginning his career with Insight Venture Partners. He is currently investing independently and has made several early-stage venture investments in the second half of 2020 alone. These investments include Canva, daring, and Roam Research, among others. During his time at Shasta, Nikhil led or co-led investments in companies including Athelas, ClassDojo, Color Genomics, Imperfect Foods, Lattice, Literati, The Farmer’s Dog, The Pill Club, and several others. Before beginning his career in VC, Nikhil was a part of the founding team at Artsy and graduated from Princeton University with a degree in Molecular Biology. He received the Spirit of Princeton Award and was advised by the school’s President in writing his thesis, “Beyond the $1000 Genome: From Third-Generation Sequencing to Personalized Medicine”. Nikhil writes regularly and publishes his essays about the “next big thing” on his Substack at nbt.substack.com -- Thank you for listening to Pod of Jake! All shares and reviews are appreciated! If you enjoy this podcast, you might like reading blogofjake.com If you prefer listening over reading, you might prefer Blog of Jake's blog on tape, available through any of your favorite podcast providers. Website: podofjake.com Twitter: @blogofjake Email: jake@blogofjake.com Call: superpeer.com/jake Support: patreon.com/blogofjake Bitcoin: 3ESGQxrJZmGqd2SifqCUiHPvah1uWtN1Zd Bitcoin Cash: qznma8vxf8kjn4v9phsfkhzd0559gm7yfsx0gkl4sf

This is The Founders' List - audio versions of essays from technology’s most important leaders, selected by the founder community. "Conflating what makes a platform work versus e.g. an infrastructure product can backfire and cause a team to have the wrong strategy for building a product or getting customers. These startups tend to fail." This is the audio version of Elad Gil's popular essay on The 3 Types of Platforms. Elad was the former Co-Founder/CEO of Color Genomics, Entrepreneur, Operating Executive at Twitter, and investor/advisor to companies like Airbnb, Stripe, Square, and Pinterest. Read the full article here - http://blog.eladgil.com/2015/01/the-3-types-of-platform-companies.html

Dr. Taylor Sittler is the co-founder & CEO of The Cusp, a digital platform that provides comprehensive, collaborative, compassionate menopause care that’s built around—and with—women. Their platform includes private chat options, 1-on-1 meetings with menopause specialists and personalized care plans. Taylor previously co-founded Color Genomics (now known as Color), a startup that created affordable genetic tests to help people understand their risk for hereditary cancer. He attended the University of Massachusetts Medical School, worked at the Massachusetts Institute of Technology and then at University of California San Diego under a Howard Hughes Medical Training Fellowship. On this episode we discussed predicting menopause, education on menopause and getting men involved in femtech. Check out The Cusp at thecusp.com Rate, Review & Subscribe!

Elad Gil is one of Silicon Valley's most successful and prominent angels of the last decade with a portfolio including the likes of Stripe, Square, Airbnb, Pinterest, Instacart, Flexport and Brex to name a few. Prior to solely company investing, Elad was an operator as Founder and CEO @ Color Genomics for their first 3 years. Before Color, Elad was a VP of Corporate Strategy @ Twitter following their acquisition of the company he founded, Mixer Labs. Before founding Mixer, Elad spent 3 years at Google where he was involved with 3 acquisition including the Android acquisition. In Today’s Episode You Will Learn: 1.) How Elad made his way into the world of startups and how that led to his investing in some of the most prominent companies of the last decade? 2.) How is the venture and startup landscape shifting right now? What does Elad make of the large multi-stage funds re-entering seed? How does Elad advise founders when it comes to taking secondaries? 3.) What are the core elements startups need to assess to fully understand their cash position? What is the optimal runway to have and to raise for today? How can founders stress test their runway models? Where does Elad see the most mistakes when it comes to runway? 4.) Does Elad believe the VC messages of "Open for Business" during COVID? How does Elad advise founders when it comes to valuation sensitivity today? What are the core terms that founders should watch out for when raising? How does Elad see venture fund reserve allocations changing? 5.) What are the core tenets of an effective layoff strategy? How should they determine the right level of aggression with which to make cuts? How can layoffs be done in a way that maintains internal culture and morale? Where does Elad see many going wrong when it comes to layoffs? 6.) Which business will thrive in COVID times? Which will die? What are the leading indicators of each? How does Elad determine in the businesses that are growing immensely during COVID, those that are sustainable growth and those which are purely due to COVID? Items Mentioned In Today’s Show: Elad’s Fave Book: Master of the Senate: The Years of Lyndon Johnson Elad’s Most Recent Investment: Deel As always you can follow Harry, The Twenty Minute VC and Elad and on Twitter here! Likewise, you can follow Harry on Instagram here for mojito madness and all things 20VC.

This week, we're having tea with serial entrepreneur and investor, Elad Gil. In a past life, Elad started the Mobile team at Google and co-founded Color Genomics. Now, he's an investor and advisor to companies including Airbnb, Pinterest, and Stripe. He's also the author of the High Growth Handbook.  In this episode, Elad shares: 1:27: How both early and late stage companies can adjust to a downturn  6:52: The amount of runway you should aim for  13:05: How to position decelerated growth to investors 18:07: Why now is a great time to start a new company Want to hear more? Like the episode? Send us a note at seriestea@mercury.com.

More than the F word, it’s the C word that scares so many of us, especially women who have a history of cancer in their family. As mothers, we try to be hyper aware of the carcinogens all around us - in the environment and nutrition - and try to steer clear of them to protect our kids. But when you’re predisposed, it’s a situation that often feels helpless because there’s nothing you could have done to prevent it. Cancer affects the world population in such an invasive way - we all know at least one person who is currently fighting cancer, is a survivor, or has passed away. Today’s episode is about the measures we can take to prevent ourselves from becoming a statistic -- how to screen for breast cancer and how to deal with it if you do happen to be diagnosed or have a friend or family member who is. Parul is a healthcare executive and cancer survivor turned inspirational speaker championing health, resilience, and a positive mindset. As the Founder & CEO of Silver Linings, Parul combines her experiences as a young working mother diagnosed with breast cancer in her early 30s, a caregiver who transformed her parents' lives with her patient advocacy, and a businesswoman with 15+ years of experience in management consulting and executive roles in consumer, technology, and healthcare companies. Parul's mission is to help improve the state of healthcare by sharing her experiences, and inspiring others to live a healthy, thankful, and fulfilling life. She has shared her personal story through her cancer blog that's been read in ~80 countries, films on survivorship and mindset, TV and radio segments, podcast interviews, and public speaking engagements. Prior to becoming a professional speaker, Parul was Head of Global B2B and B2B2C Marketing at Color Genomics, where she built and led the team responsible for the entire sales and customer success marketing funnel for Color’s enterprise and clinical channels. Before that, as VP of Growth for Weddington Way, Parul led the vertical integration and retail growth strategies that led to the company's acquisition by Gap Inc. As a management consultant at Bain & Company, Parul led teams advising Fortune 500 companies and private equity firms, and helped launch Bain's first consulting office in India. Parul currently serves on the advisory board for Stanford's Health Communication Initiative and early stage start-ups. Parul holds a Bachelor of Science degree in Electrical Engineering and Computer Science and a Minor in Economics from the Massachusetts Institute of Technology (MIT) and an MBA from Harvard Business School. Parul and I are connected through our mutual friend Payal Kadakia Pujji. Payal is the founder of ClassPass which is the first female led start-up to hit unicorn status this year and Creative Director Sa Dance Company - Parul and I are members. I love that we are bonded by our passion for Indian dance. Meet My Guest: WEBSITE: ParulSomani.com INSTAGRAM: @pdsomani TWITTER: @pdsomani FACEBOOK: /DesigningSilverLinings LINKEDIN: Parul Somani  Press: THE SOUTH ASIAN TIMES: Parul Somani: Inspiring Others with Silver Linings 

Can we bridge the cultural gap between health tech and health care? What happens when "fail fast, fail often " and "move quickly and break things" meets patient care? Dr. Jill Hagenkord, the co-founder of MDisrupt and previous Chief Medical Officer at Complete Genomics, Invitae, 23 and Me and Color Genomics joins us.

Color Genomics burst on the scene in 2015, offering breast cancer susceptibility testing at a fraction of the price of other laboratories.

Elad Gil really needs no introduction - he’s been integral in some of the most interesting and iconic companies in the valley. After fulfilling a PhD at MIT and a brief stint at McKinsey and Company, Elad went on to join Google and Twitter through their hypergrowth years; he joined Twitter when there were 90 employees and two and a half years later, he had helped the company scale to 1,500+. Elad is the founder and former CEO of Color Genomics and has invested in 20+ companies valued today at over $1B, including Airbnb, Coinbase, Checkr, Gusto, Instacart, OpenDoor, Pinterest, Square, Stripe and Wish. This episode was a ton of fun - I talked to Elad about his perspective on industry towns, why there aren’t many founders that come from Amazon, Microsoft, or Apple , his genomics research, how he evaluates companies and what are the most counterintuitive principles he taken away from investing in over 20 unicorns.

Anis Uzzaman, Ph.D. is the Founder and General Partner of Pegasus Tech Ventures. Anis also serves as the CEO of the company, overlooking overall management and operations. Located in Silicon Valley, USA, Pegasus Tech Ventures provides early stage and final round funding. With several multi-million dollar funds under management, Pegasus Tech Ventures focuses its investment in IT, Health IT, Artificial Intelligence, IoT, Robotics, Big Data, Virtual Reality, Augmented Reality, FinTech and Next Generation Technologies. Anis has invested in over 140 startups in the United States, Japan, and South East Asia. Some of the prominent USA startups in the Pegasus Tech Ventures portfolio include Vicarious, Color Genomics, Genius, Affectiva, Afero, x.ai, and ShareThis. Anis is an investor and board member of Tech in Asia, the largest tech media blog in Southeast Asia. Anis also sits on the board of directors of Affectiva, Lark, Sano, Asteria, and I AND C-Cruise. Anis is also the Founder and Chairman of Startup World Cup, the largest global startup competitions for innovation and entrepreneurship. The regional competitions happen in 40 different countries with the Grand Finale happening in Silicon Valley and the Grand Champion Startup is awarded with US$ 1 million in investment prize. This is the largest global competition of its type sponsored by the Pegasus Tech Ventures team. Anis holds a B.Eng. degree from Tokyo Institute of Technology in Japan, an M.S. in Engineering from Oklahoma State University, and a Ph.D in Computer Engineering from Tokyo Metropolitan University in Tokyo, Japan. Anis is an honored guest speaker in international conferences, workshops and seminars, has published more than 30 technical papers, and is the author of the “Startup Bible – The Silicon Valley Way of Developing Success” and “A Global Investor’s Viewpoint on Japanese Companies” that launched in Japan; “Startup Success – The Six Steps To Building A Successful Startup” that launched in Korea; “Startuppedia – Guide To Build Startup – Silicon Valley Way” that launched in Indonesia; and “Startup Bible – Silicon Valley Way of Developing a Successful Startup” that launched in Taiwan.SOCIAL LINKS (twitter, facebook, linkedin) if applicable:Pegasus Tech Ventures: https://www.pegasustechventures.com/Let your voice be heard. Check out www.positivephil.comBooks I am reading Right Nowhttps://amzn.to/3236WSiwww.positivestocks.comwww.ambitiousstocks.comwww.microcapstocknews.com

Anis Uzzaman, Ph.D. is the Founder and General Partner of Pegasus Tech Ventures. Anis also serves as the CEO of the company, overlooking overall management and operations. Located in Silicon Valley, USA, Pegasus Tech Ventures provides early stage and final round funding. With several multi-million dollar funds under management, Pegasus Tech Ventures focuses its investment in IT, Health IT, Artificial Intelligence, IoT, Robotics, Big Data, Virtual Reality, Augmented Reality, FinTech and Next Generation Technologies. Anis has invested in over 140 startups in the United States, Japan, and South East Asia. Some of the prominent USA startups in the Pegasus Tech Ventures portfolio include Vicarious, Color Genomics, Genius, Affectiva, Afero, x.ai, and ShareThis. Anis is an investor and board member of Tech in Asia, the largest tech media blog in Southeast Asia. Anis also sits on the board of directors of Affectiva, Lark, Sano, Asteria, and I AND C-Cruise. Anis is also the Founder and Chairman of Startup World Cup, the largest global startup competitions for innovation and entrepreneurship. The regional competitions happen in 40 different countries with the Grand Finale happening in Silicon Valley and the Grand Champion Startup is awarded with US$ 1 million in investment prize. This is the largest global competition of its type sponsored by the Pegasus Tech Ventures team. Anis holds a B.Eng. degree from Tokyo Institute of Technology in Japan, an M.S. in Engineering from Oklahoma State University, and a Ph.D in Computer Engineering from Tokyo Metropolitan University in Tokyo, Japan. Anis is an honored guest speaker in international conferences, workshops and seminars, has published more than 30 technical papers, and is the author of the “Startup Bible – The Silicon Valley Way of Developing Success” and “A Global Investor’s Viewpoint on Japanese Companies” that launched in Japan; “Startup Success – The Six Steps To Building A Successful Startup” that launched in Korea; “Startuppedia – Guide To Build Startup – Silicon Valley Way” that launched in Indonesia; and “Startup Bible – Silicon Valley Way of Developing a Successful Startup” that launched in Taiwan.SOCIAL LINKS (twitter, facebook, linkedin) if applicable:Pegasus Tech Ventures: https://www.pegasustechventures.com/Let your voice be heard. Check out www.positivephil.comBooks I am reading Right Nowhttps://amzn.to/3236WSiwww.positivestocks.comwww.ambitiousstocks.comwww.microcapstocknews.com

Darrin Crisitello, Vice President, Global Sales, Marketing, and Operations at Color Genomics & IndieBio Adjunct Partner featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio. IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology. We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B. IndieBio is a member of SOSV a $700M global fund focused on lasting impact. Follow on www.twitter.com/indbio

Serial entrepreneur and Color founder Elad Gil joins Founder Real Talk to share insights and his experiences in starting and building high growth start-ups. We talk about how a founder’s role changes over time, how to build a team that scales, and what conditions need to be in place for “high growth” to happen. His recent book “High Growth Handbook” is a must-read for any startup founder starting to scale up or hoping to get to that point one day. The book is also highly relevant for executives at high growth startups. Elad Gil is an entrepreneur, operating executive, and investor or advisor to private companies such as Airbnb, Coinbase, Checkr, Gusto, Instacart, OpenDoor, Pinterest, Square, Stripe, Wish, and others. He co-founded and is the Chairman of Color Genomics, and was its CEO until December 2016. Before that, he was the VP of Corporate Strategy at Twitter, where he also ran various product (Geo, Search) and other operational teams (M&A and corporate development). Elad joined Twitter via the acquisition of Mixer Labs, a company where he was co-founder and CEO. Mixer Labs ran GeoAPI, one of the early developer-centric platform infrastructure products. Elad spent many years at Google, where he started the mobile team and was involved in all aspects of getting that team up and running. He was involved with three acquisitions (including the Android team) and was the original Product Manager for Google Mobile Maps and other key mobile products. Elad received his Ph.D. from the Massachusetts Institute of Technology and has degrees in Mathematics and Biology from the University of California, San Diego. Highlights from the episode: 3:18 What is your definition of “high growth” and what does it look like when a company is in that stage? 5:32 What conditions must be met before a company reaches “high growth?” 7:06 What is the role of a founder/CEO in a high growth situation? How do CEO priorities change as the company scales? 9:03 How should a founder/CEO of a high growth company define “winning?” 10:36 What types of skills does a leader need to develop as the company scales? 12:14 Any tips for time management? 14:20 Is it important to have a chief of staff? What should someone look for in that role? 17:31 Do you think CEO coaches are helpful? Do you think mentors are helpful? 18:28 How do you know when to add a specific executive? Which executives should be priority hires? 19:19 What is the best way to ensure you’re hiring the right person? 22:45 How do you think about the tradeoff between functional expertise and culture fit in hiring for an executive position? 25:03 What is the role of an independent board member? What traits should you be looking for in this role? 27:23 How should a founder think about the process of looking for a CEO? 29:44 When thinking about financings, do you recommend founders accept capital before they reach defined milestones? What are the pros and cons? 32:11 What’s a favorite book or blog you recommend for founders? 32:44 Name a growth stage company you admire and why? 33:42 What piece of advice were you given as an entrepreneur that served you well?

The post E860: Elad Gil, Angel Investor (Airbnb, Coinbase, Square) & Operator (Color Genomics, Google), shares masterclass on fundraising timeline & process, landing & optimizing investors, notes & equity terms/trade-offs, common mistakes & more @ LAUNCH Incubator appeared first on This Week In Startups.

The post E860: Elad Gil, Angel Investor (Airbnb, Coinbase, Square) & Operator (Color Genomics, Google), shares masterclass on fundraising timeline & process, landing & optimizing investors, notes & equity terms/trade-offs, common mistakes & more @ LAUNCH Incubator appeared first on This Week In Startups.

In this episode, Eric talks about building a capital intensive business across multiple geographies and how he balances speed vs. scale. He also discusses his controversial take on hiring, how poker influences his outlook on business, and how to transition from an IC to a manager.Eric Wu is co-founder and CEO of Opendoor, a consumer technology company that is reinventing how people buy and sell real estate. Prior to Opendoor, Eric was the founder and CEO of Movity.com, a geo-data analytics company acquired by Trulia.com in 2011. At Trulia, Eric led location, social, and consumer product development. Eric also co-founded RentAdvisor.com, which was later acquired by Apartment List, and runs a real estate fund that has invested in over 100 multi-family units. Eric has been an investor and advisor to a number of startups and social enterprises including Watsi, CareMessage, and Color Genomics.

In this episode, Eric talks about building a capital intensive business across multiple geographies and how he balances speed vs. scale. He also discusses his controversial take on hiring, how poker influences his outlook on business, and how to transition from an IC to a manager. Eric Wu is co-founder and CEO of Opendoor, a consumer technology company that is reinventing how people buy and sell real estate. Prior to Opendoor, Eric was the founder and CEO of Movity.com, a geo-data analytics company acquired by Trulia.com in 2011. At Trulia, Eric led location, social, and consumer product development. Eric also co-founded RentAdvisor.com, which was later acquired by Apartment List, and runs a real estate fund that has invested in over 100 multi-family units. Eric has been an investor and advisor to a number of startups and social enterprises including Watsi, CareMessage, and Color Genomics.

Startup advisor and Color Genomics co-founder Elad Gil talks with Recode's Kara Swisher about his new book, "High Growth Handbook: Scaling Startups from 10 to 10,000 People." In this episode:00:03:30 - Why Gil stepped down as CEO of Color00:06:00 - Why he wrote "High Growth Handbook"00:09:52 - Is there too much reinvention in tech businesses?00:11:25 - Startup myths and Rachleff's Law00:17:20 - Contrarians are usually wrong!00:23:00 - How to build a board and evolve it as your company grows00:29:14 - The "old-timer" problem00:32:14 - The Sheryl Sandberg effect and when CEOs should step aside00:37:10 - Is innovation dying in Silicon Valley?00:41:05 - Are startups threatened more by the Big 5 or their own founders?00:43:59 - The dangers of Silicon Valley losing its optimism00:52:05 - San Francisco's bad governance Learn more about your ad choices. Visit megaphone.fm/adchoices

Carol and her new co-host Jason Kelly speak to Peter Tchir, Head of Macro Strategy at Academy Securities and General Anthony Tata, Advisory Board Member at Academy Securities, about the Turkey currency crisis and possible contagion. Liz Capo McCormick, Bloomberg News Reporter, explains how women who want to manage money seem to be having better luck doing it someplace other than Wall Street. Shira Ovide, Bloomberg Opinion Technology Columnist, on her Bloomberg Businessweek story about Amazon capturing 5% of American retail spending. Elad Gil, Co-Founder & Chairman of Color Genomics, discusses his book "High Growth Handbook" on the world of startups. And we Drive to the Close with John Petrides, Managing Director at Point View Wealth Management. 

Carol and her new co-host Jason Kelly speak to Peter Tchir, Head of Macro Strategy at Academy Securities and General Anthony Tata, Advisory Board Member at Academy Securities, about the Turkey currency crisis and possible contagion. Liz Capo McCormick, Bloomberg News Reporter, explains how women who want to manage money seem to be having better luck doing it someplace other than Wall Street. Shira Ovide, Bloomberg Opinion Technology Columnist, on her Bloomberg Businessweek story about Amazon capturing 5% of American retail spending. Elad Gil, Co-Founder & Chairman of Color Genomics, discusses his book "High Growth Handbook" on the world of startups. And we Drive to the Close with John Petrides, Managing Director at Point View Wealth Management.  Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Elad Gil is an entrepreneur, operator, and investor. He cofounded Color Genomics and Mixer Labs. Worked at Google and Twitter. And has invested in companies including Airbnb, Coinbase, and Stripe.He just released the High Growth Handbook, which is a guide to scaling startups published by Stripe Press.It contains tactical advice on key issues for post product-market fit companies such as the role of the CEO, hiring executives, late stage fundraising, M&A, and other topics. It also includes interviews with people in tech, including Sam Altman, President of YC Group.You can find the High Growth Handbook on Amazon.The YC podcast is hosted by Craig Cannon.We're accepting applications from startups for the Winter 2019 funding cycle. Apply here.***Topics01:04 - Why should an entrepreneur read the High Growth Handbook?5:35 - On Marc Andreessen's comment, "The companies that charge more tend to grow faster."6:50 - Myths about startups7:50 - Leon Coe asks - What types of businesses do you avoid investing in?9:20 - Things to just say 'no' to12:40 - Companies that may be too early14:52 - On Naval Ravikant's comment, "The most successful class of people in silicon valley on a consistent basis are either the venture capitalists, or people who are very good at identifying companies that have just hit product/market fit. They have the background, expertise, and references that those companies really want to help them scale."17:41 - On Claire Hughes Johnson's "Guide to Working with Claire"19:40 - Masud Hossain asks - How did most of the companies you interviewed get their first 10 customers?20:55 - Masud Hossain asks - Is content really king?22:50 - Narayan Mallapur asks - Where do founders make the most mistakes? Is it on hiring? What steps should they take to avoid these pitfalls24:55 - Brianne Kimmel asks - What are some lessons learned in highly regulated sectors? When should you hire a General Counsel? How do you prioritize public policy and lobbying efforts?29:05 - Media cycles30:55 - Marius Chawa asks - What are the top three things a startup "must" achieve before VC firms would line up to fund them?34:45 - Taylor Caforio asks - My company is at our early MVP stage. What is he best way to find a balance between giving our earliest customers the 6 star treatment while also having swift and exponential growth in the back of our minds.36:54 - Tanmay Khandelwal asks - When you are sprinting in growth stage, how do you predict engineers required and hire accordingly?38:41 - TD Bryant II asks - When your organization is experiencing exponential growth, how do you choose which functions to outsource vs build/hire?41:50 - Andrew Pikul asks - Who is your favorite Dragon Ball (Z/GT/Super) villain?

with Elad Gil (@eladgil) and Chris Dixon (@cdixon) There's a lot of knowledge out there -- and networks of talent (especially in Silicon Valley) -- on what to do in the early stages of a company, going from 0 to 1, and even in going from 1 to 100... but what about beyond that? It's not as simply linear as merely doubling or tripling resources and org structures; it's actually much more complex on many levels, communication to coordination. Because with great scale comes great complexity... and many, many more places for things to break down. So how should founders/CEOs of growing tech startups think about everything from hiring (including key executives) to product management (what is it, really, beyond common myths/misconceptions around the role?) to thinking about late-stage financing, M&A, and other key aspects of building a company? This episode of the a16z Podcast shares both specific answers to -- and general mindsets for thinking about -- these questions. Chris Dixon, general partner on a16z crypto, interviews Elad Gil, investor/advisor to numerous tech companies; co-founder of Color Genomics; formerly of Google and also co-founder and CEO of Mixer Labs (acquired by Twitter, where he also became a VP). He's the author of the new book, The High Growth Handbook, on scaling companies from 10 to 10,000 people. But the two also explore the growth -- and evolution -- of market and tech trends, including the continuation of mobile/cloud; machine learning (and silicon); crypto; and finally, longevity -- both in the near term and further out in the future. Should people -- and even companies for that matter -- really live longer?

The Sunday Times tech correspondent Danny Fortson brings on Othman Laraki, founder of Color Genomics, to talk about taking genomics to masses by reducing the cost by an order of magnitude (4:45), the importance of genetic counselling (6:45), the ‘value for money’ equation (12:35), how data is treated (14:55), starting the company after leaving Twitter (20:35), the slow evolution of genomics’ role in consumer health (23:00), how these tests may be abused by insurers (25:50), raising $150m (28:45), the coming healthcare revolution (31:15), and choosing treatable diseases (34:20). PLUS: Ellen Matloff, a genetic counselor and founder of My Gene Counsel, to talk about whether ignorance is bliss (36:40), the danger of misdiagnosis (38:25), why consumer genetics is here to stay (41:20), and why your genetic data may already be in a company’s hands (43:00). See acast.com/privacy for privacy and opt-out information.

Hemant Taneja is Managing Director @ General Catalyst, one of the world's leading venture firms of the last decade with Airbnb, Stripe, Snapchat, Hubspot and Gusto all in their portfolio. As for Hemant, he has led investments at GC in Stripe, SNAP, Grammarly, Gusto, Livongo, Color Genomics, Class Dojo and more. He also directs the GC Stripe Platform Fund, a $10 million initiative to help start new ventures that are built on top of the Stripe Connect platform. On the educational front, Hemant holds 5 degrees from MIT and sits on the board of Khan Academy. In Today’s Episode You Will Learn: 1.) How Hemant made his way from 5 degrees at MIT and wanting to be an academic to pursuing startups in the world of VC with General Catalyst? 2.) Question from Sam @ ClassDojo: What were the hardest elements of establishing GC on the West Coast? With hindsight today, what would Hemant do differently given the chance? How does Hemant think about the development and ability to accelerate the creation of local reputation? What is crucial and works most effectively? 3.) How does Hemant respond to Elad Gil's "everyone is looking for the next truly deep dein to explore"? Why is Hemant so bullish that we are in the "golden age of venture capital"? Why does Hemant believe that "scale" as a key measure has run it's course? What does Hemant's thesis of the future of "unscaling" really mean? 4.) How does Hemant analyse price sensitivity in todays forthy environment? How has his relationship to price changed over time? With regards to price, what have been some of his biggest regrets and learnings drawn from real-world examples? How does Hemant assess reserve allocation? Why does he think pro-rata is a lazy posture? 5.) Hemant has said on boards for over 1,800 hours, so what does Hemant belive makes the truly special board members? How does Hemant think about first building that rapport and "intimacy" with the founder? Secondly, how important does Hemant believe it is to build similar relations with other board members? Which founder exemplifies the best board management in Hemant's mind? Items Mentioned In Today’s Show: Hemant’s Fave Book: Home Deus Hemant’s Most Recent Investment: Spring Discovery As always you can follow Harry, The Twenty Minute VC and Hemant on Twitter here! Likewise, you can follow Harry on Instagram here for mojito madness and all things 20VC. Highfive makes meetings better for thousands of organizations with insanely simple video conferencing designed for meeting rooms. It’s the easiest-to-use solution, with all-in-one hardware and intuitive cloud software. Plus, it’s a high-quality experience with industry-leading audio powered by Dolby Voice. It’s so easy to use, that there’s no pin codes or app downloads. Just click a link in your browser, and you’re in the meeting. With customers in over 100 countries, Highfive is already trusted by the likes of Evernote, Expensify, and Betterment and you can learn more by simply heading over to highfive.com. Culture Amp is the platform that makes it easy to collect, understand and act on employee feedback. From onboarding surveys to company-wide engagement, individual effectiveness and more, the platform manages multiple sources of feedback and connects the dots for you and that is why companies like Slack, Nike, Oracle and Lyft all trust Culture Amp. It enables leaders to make better decisions, demonstrate impact and turn your company culture into a competitive edge.  So put your people and culture first and find out more on cultureamp.com.

CNBC's Chrissy Farr talks with Othman Laraki, Co-founder & CEO of gene testing company Color Genomics, about advances in genetic testing, gene counciling, and what the future holds in the field with commentary by CB Insights Digital Health Analyst, Nikhil Krishnan.

Shannon met former Kristen Ulmer at the Spartan Race in Lake Tahoe. Kristen is the author of The Art of Fear: Why Conquering Fear Won’t Work and What to Do Instead. In this episode she shares her journey with fear and discusses how we deal with fear. Kristen Ulmer started out as a professional athlete, she was the best female big mountain extreme skier in the world, a status she kept for 12 years. She risked her life on a pair of skis, jumping off cliffs and skiing “you fall you die” descents. Kristen was voted “Most Fearless Woman in America” by the outdoor industry beating women in all sports and disciplines, not just skiing.  While Kristen felt fearless, she realized after looking under her everyday reality that fear was with her in every single moment of every day and in every decision she made. She came to this realization after retiring her ski career in 2003 and studying with a Zen master for 15 years. Kristen started off as a mindset sports coach and currently is a fear specialist. Now Kristen’s whole world is talking about and thinking about fear. When Kristen retired, it wasn’t because her career was over; it was because she got to the point where she hated skiing. Every time winter would roll around she would cringe. Kristen started getting injured more and she had PTSD from seeing a lot of her friends die in the mountains and having many near death experiences herself. She was exhausted all the time and felt that there was something really wrong. So Kristen quit her ski career and set out to find out what was wrong. This is when she met the Zen master with whom she studied with for 15 years. Within the first ten minutes of working with her Zen master, Kristen discovered that she had been repressing her fear for years in order to ski the way that she wanted. Repressing your fear only works for about ten years then things begin to go south. Kristen started working with other athletes, and found they were underperforming due to their repressed fear. She also worked with people dealing with depression, panic attacks, anxiety disorders, and insomnia, discovering that repressing fear caused these problems too. Kristen realized that she needed to declare herself a fear specialist and write a book.  In a fear exercise, Kristen asked Shannon to talk to her like Kristen is Shannon’s fear. Kristen points out that fear is a huge part of our lives and with us everyday, in everything that we do, and how we treat our fear is ultimately how we treat our self. It’s important to have the best relationship with fear and it’s important how we talk to our fear. How do you talk to your fear? Do you tell it to go away? Do you tell it you hate it? Do you ignore it? If you hate your fear, how does that make fear feel? Darkness is not the opposite of light, it is just the absence of light. “Those who are unaware they are walking in darkness will never see the light.” –Bruce Lee If we see fear as a dark voice, then that is how it will appear. If we try to crush fear, push it away, conquer it, lock it away in the basement and throw away the key, then fear will come out in a very dark way. How would you feel if you were locked in the basement? Fear will not be denied. If you repress it, fear will come out as anger, sadness, or depression. It is a bad idea to repress fear, but it is something many of us do, and our fear comes out in a dark way. Fighting your fear creates a war in your subconscious. It is an exhausting war that you cannot win because fear is a part of life. Take Action: First, change your language surrounding fear. Instead of saying “Fear and anxiety is a problem in my life,” you should say, “Because I’m unwilling to deal with my fear and anxiety in an honest way that has become a problem in my life.” Second, have a fear practice: Identify where the discomfort is in your body. Recognize that it’s normal and natural to feel fear. Notice if you have any resistance to your fear. Can you lower your resistance? For 30 seconds feel your fear. Feel that discomfort without trying to get rid of it. “Courage is not the absence of fear, it is the ability to act in the presence of fear.” – Bruce Lee #AAHA (Awesome Asians and Hapas) Kristen nominated her friend Bill Tai who is her kiteboarding buddy. Bill Tai is a Silicon Valley entrepreneur, philanthropist, and a fantastic kiteboarder. Tai is the Founding Chairman of Treasure Data, board director of BitFury and Voxer, seed investor in Canva, Color Genomics, Tweetdeck/Twitter, Wish.com, and Zoom Video, and Adjunct Professor of Innovation & Economic Development at Curtin University. He just started ACTAI, which is a group that brings together entrepreneurs, innovators, athletes, artists, tech heads, and thought leaders supporting causes around the world. Bill Tai, officially from the Bruce Lee Podcast, you’re awesome! #BruceLeeMoment  Kristen shares her #BruceLeeMoment: “Of course everyone knows who Bruce Lee is, I’m no exception. I am really drawn to his quotes, the second I hear a quote of his it just goes into my soul. I think of “Be water my friend. Water can flow.” Which your dad said. When I think of flow, I think of water, I think of myself as a hose. And I have these droplets of water coming into, through, and out of my life. These droplets of water are fear, anger, joy, love, a thought, a belief, they all come into, through, and out of my life just influencing me. I remember one time I was invited to compete in this very prestigious competition to see who the best female/male skier in the world was. And I didn’t want to do it, I just wanted to make movies. I felt obligated to go though because they were paying me to be there, but I felt even more obligated to win the thing, if I didn’t win this thing it would be humiliating. It was the best of two runs and after the first run I was not winning. I just rode the chairlift, I had two hours before my next run and I was feeling frustrated. That was a droplet of water. I was embarrassed, that was a droplet of water. I was afraid, of looking like a fool, I felt like a fraud. That I was pulling the wool over these guys’ eyes, maybe I’m not the best. I had all these really unpleasant, uncomfortable [feelings], fear of failure, coming into, through [me]. But because I was in flow with them because they were like water droplets, they were coming into my eyes and motivating me and helping me come alive and be more sharp. By the time two hours passed, and I got in the gate again, I went and skied this run that I jumped off a 70ft cliff. I took 4th overall for the men out of 120 men, and of course won for the women. It was this incredible moment where I was completely in flow with all these unpleasant experiences not resisting any of them and they all helped me be amazing for my second run." Thank you Kristen for doing your teaching and for sharing your insights with our community! Everyone should go out and get Kristen’s book “The Art of Fear.” Thank you so much for joining us! Read our full show notes at Brucelee.com/podcast Share your #AAHAs, #BruceLeeMoments, and #TakeAction progress with us at hello@brucelee.com.

During this week’s episode of STACK That, we dive into the world of data and machine learning in healthcare. We sat down with Othman Laraki from Color Genomics, a company that’s making major strides into mapping the human genome and helping the medical world build better solutions for discovering predispositions to disease.

If you love design and user experience, this is a podcast for you. Today we speak with Wendy McKennon, head of user experience at Color Genomics -- a digital health startup with a mission to help people make the most of their health information.   Color Genomics is most known for its lower-cost $250 physician-ordered genetic test that is available to determine an individual's breast and ovarian cancer risk. The lower cost of this test is transformative in the way it changes how people can afford and access this information for their personal health. In addition, the company also has expanded to offer testing for the eight most-common hereditary cancers, as well as a test for high cholesterol risk.    When Wendy joined the Color Genomics team as its first designer, she worked with only five others. Today, she leads product and design for a team double that size. In episode 54 of I Want Her Job: The Podcast, we speak with Wendy about what it's like to work in user experience, the qualities Wendy looks for when hiring for her team, her biggest source of inspiration and learn about the incredible inspirations in her life that have shaped her interests.

This week we discuss precision medicine and genetic testing with Dr. Jill Hagenkord, Chief Medical Officer at Color Genomics, which provides genetic testing for hereditary cancer and high cholesterol risks as well as preventative health services, including genetic counseling. We spoke to her about recent breakthroughs in cancer research and precision medicine, the benefits of testing for cancer-causing gene mutations, and what it means for patients, families, and medical providers. Learn more about your ad choices. Visit megaphone.fm/adchoices

Apple plans to spend $1B on original shows, Color Genomics raises $80M, and Google's pollen play

Elad Gil is the Founder of Color Genomics, however, Elad is also one of the most prominent angel investors in the valley with a portfolio including the likes of Airbnb, Stripe, Square and Pinterest just to name a few. Prior to founding Color Genomics, Elad was VP of Corporate Strategy @ Twitter where he ran various product teams including geo and search. Before that, Elad spent 3 years at Google where he started Google's mobile team and was involved with 3 acquisitions including Android.   In Today’s Episode You Will Learn: 1.) How Elad made his way into the world of angel investing and came to invest in Airbnb, Square and Stripe? 2.) Why does Elad take a very market-driven approach to investing? Does this go against the very founder-first approach taken by many in the valley today? 3.) Why does Elad believe that people totally mislead themselves when sizing up potential markets? How should markets be addressed and evaluated? What are the core elements to look for? 4.) Should VC services always be bundled together? Is there a smarter way to decouple these services to make the best products for founders? How could this look in reality? 5.) How does Elad approach valuation? Does Elad agree with Peter Fenton that 'all best companies always seem expensive at the time and cheap in hindsight'?  Items Mentioned In Today’s Show: Elad’s Fave Book: The Wind-Up Bird Chronicle Elad’s Most Recent Investment: Checkr As always you can follow Harry, The Twenty Minute VC and Elad on Twitter here! Likewise, you can follow Harry on Snapchat here for mojito madness and all things 20VC. eShares is the No 1 Cap Table Management platform, allowing for equity management, 409A valuations, and liquidity, all in one place. eShares is made for companies of all sizes with over 5,000 trusted customers including the likes of Squarespace, Kickstarter, and DoorDash just to name a few. To try out the must have service of the industry, simply head over to esharesinc.com it is a must. Fond is the employee engagement suite with 3 core products, rewards: a recognition platform for rewarding achievements and milestones, perks: a premium corporate discounts program to show employees you care about them and then finally engagement IQ, a free employee engagement survey that allows you to measure the health of your organization. To check it out head over to fond.co

Katie Jacobs Stanton knows how to create her own options. Stanton, a veteran of Twitter, Google, Yahoo, and a presidential administration, now serves as chief marketing officer of genetic testing startup Color Genomics. Her professional journey from East Coast to West, and back and forth again, has given her rare insight into the workplace cultures that shape us today. I sat down with her for the Fortt Knox podcast to talk about the environment for women in tech, and her journey to the executive ranks in Silicon Valley. Learn more about your ad choices. Visit megaphone.fm/adchoices

Color Genomics co-founder and CEO Othman Laraki talks with Recode's Kara Swisher about why we're on the verge of a healthcare revolution. Laraki, whose company tests buyers' genes for certain hereditary cancers, says the future of medicine will be defined by our ability to read data from our bodies. While most of that data used to be recorded on paper and stored at hospitals, now it's largely being generated and stored on our smartphones; he predicts that to achieve truly personalized medicine, we will need artificially intelligenct software that can comb this data, changing the role of doctors in the process. Learn more about your ad choices. Visit megaphone.fm/adchoices

Gil, co-founder of a start-up that tests your genes for genetic mutations that can lead to cancer, explains why – after selling his last company to Twitter and helping start Google's mobile offerings – low-cost DNA testing was his next focus. Podcast with Laura Mandaro of USA TODAY and Shruti Gandhi of Array Ventures.

The O'Reilly Radar Podcast: Color Genomics, genetic testing access, and the future of precision medicine.This week, I chat with Othman Laraki, co-founder of Color Genomics. We chat about challenges and opportunities in genetic testing, the future of precision medicine, and the hurdles medicine and health care are currently facing (and how we can overcome them).Here are some highlights: Genetics testing for everyone Genetics, we felt, had come to a point where there was an opportunity to have a very big impact by essentially mixing some of the best of the biology world with software—in many ways, genetics had started to become, in part, a software problem. It felt like it was starting to be possible to build products that made genetics accessible to a much broader population by both dropping costs as well as increasing access, so making this information more accessible to a much broader population in a scalable way. ... For example, one of the things we did that we're very proud of is we created this program called the Every Woman Program, where whenever someone buys a test from Color, they can also contribute to fund testing for someone who can't afford it. Then we work with a number of cancer centers, for example at UCSF and the University of Washington, Morehouse in Georgia, and a number of others, where each one of those centers works with underprivileged populations, and they can provide tests for free for people who can't afford it but who the doctors think should get tested. Opportunities in machine learning One of the big opportunities for machine learning in genetics, for example, is around the interpretation of the effects of specific genetic changes. Right now, there are set of guidelines or processes that are used by the industry around the interpretation of how a specific mutation impacts a gene. It's a structured process that's very labor intensive, but it's one of those areas where over time is going to become something that's very heavily solved by machine learning because there's a lot of data that can be used to train a model instead of purely running it in a manual way. The industry is going to evolve quite a bit over the next few years and machine learning is going to have very substantial impact there. Using the full data set of the human body Each one of us is carrying and generating a tremendous amount of data in our daily lives, whether it's our genome, our microbiome, etc., etc. So far, the link between that data and health practice had been through the path of research and translation to a few proxies, essentially, where researchers collect a lot of data, they do a research study, it turns into a set of conclusions, and that over time gets turned into a few rules that get introduced into medical practice. If someone's lipid levels are at this level, etc., then you draw these kinds of conclusions. Now, we're coming to the point where the amount of data that a doctor will be able to use in a real way to make medical decisions is going to be the full data set of our bodies, which is very exciting and can have a very big impact. Long-tail distribution of genetic insights In some ways, I feel right now we've come to this point where there's been enough data and science behind us that we can already create a lot of value, and that allows the bootstrapping of doing things at a massive scale that really takes us to that long-tail distribution of insights around how genetics work and how the body works.

The O'Reilly Radar Podcast: Color Genomics, genetic testing access, and the future of precision medicine.This week, I chat with Othman Laraki, co-founder of Color Genomics. We chat about challenges and opportunities in genetic testing, the future of precision medicine, and the hurdles medicine and health care are currently facing (and how we can overcome them).Here are some highlights: Genetics testing for everyone Genetics, we felt, had come to a point where there was an opportunity to have a very big impact by essentially mixing some of the best of the biology world with software—in many ways, genetics had started to become, in part, a software problem. It felt like it was starting to be possible to build products that made genetics accessible to a much broader population by both dropping costs as well as increasing access, so making this information more accessible to a much broader population in a scalable way. ... For example, one of the things we did that we're very proud of is we created this program called the Every Woman Program, where whenever someone buys a test from Color, they can also contribute to fund testing for someone who can't afford it. Then we work with a number of cancer centers, for example at UCSF and the University of Washington, Morehouse in Georgia, and a number of others, where each one of those centers works with underprivileged populations, and they can provide tests for free for people who can't afford it but who the doctors think should get tested. Opportunities in machine learning One of the big opportunities for machine learning in genetics, for example, is around the interpretation of the effects of specific genetic changes. Right now, there are set of guidelines or processes that are used by the industry around the interpretation of how a specific mutation impacts a gene. It's a structured process that's very labor intensive, but it's one of those areas where over time is going to become something that's very heavily solved by machine learning because there's a lot of data that can be used to train a model instead of purely running it in a manual way. The industry is going to evolve quite a bit over the next few years and machine learning is going to have very substantial impact there. Using the full data set of the human body Each one of us is carrying and generating a tremendous amount of data in our daily lives, whether it's our genome, our microbiome, etc., etc. So far, the link between that data and health practice had been through the path of research and translation to a few proxies, essentially, where researchers collect a lot of data, they do a research study, it turns into a set of conclusions, and that over time gets turned into a few rules that get introduced into medical practice. If someone's lipid levels are at this level, etc., then you draw these kinds of conclusions. Now, we're coming to the point where the amount of data that a doctor will be able to use in a real way to make medical decisions is going to be the full data set of our bodies, which is very exciting and can have a very big impact. Long-tail distribution of genetic insights In some ways, I feel right now we've come to this point where there's been enough data and science behind us that we can already create a lot of value, and that allows the bootstrapping of doing things at a massive scale that really takes us to that long-tail distribution of insights around how genetics work and how the body works.

Episode 25 of Startup School Radio: Host Aaron Harris interviews Elad Gil, the founder of Color Genomics. They talk about Elad's path from academia to startups, the early days of mobile, and starting a companies in widely disparate fields.